Holds 2 active US DMFs and 2 valid CEPs for vigabatrin, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.
Holds 2 active US DMFs and one valid CEP for vigabatrin, filing since 2018. Its GMP is recognised in 1 market.
Holds one active US DMF for vigabatrin, filing since 2017. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for vigabatrin, filing since 2018. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs for vigabatrin, filing since 2020. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 7 markets.
Holds one active US DMF for vigabatrin, filing since 2019. Its 2025 FDA inspection closed as VAI.
Holds one valid CEP for vigabatrin, filing since 2024. Its GMP is recognised in 2 markets.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystContract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for vigabatrin and what filings they hold.
Chat with Fred, your AI analyst| Year | Median | Exporters |
|---|---|---|
| 2025 | $703.56 | 11 |
| 2024 | $750.00 | 8 |
| 2023 | $840.02 | 12 |
| 2022 | $940.27 | 5 |
US dollars per kilogram, customs export unit values.